Research BRAF
Related Resources for this page:
- Future Directions
- Antibody-Drug Conjugates
- A brief history of ADCs
- Current research in ADCs
- Cytotoxic agent
- Emerging therapeutic options
- Emerging therapeutic options
- HER Signaling
- How are ADCs designed to work?
- Glossary
- Monoclonal antibody
- Research ADCs
- Slide decks and videos
- Stable linker
- Targeting cancers with ADCs
- Trastuzumab Emtansine (T-DM1)
- What are ADCs?
- Antibody-Drug conjugates
- Apoptosis
- Bispecific Monoclonal Antibodies
- Glycoengineered Antibodies
- Non-Antibody Biologics
- Targeted Small Molecules
- Apoptosis
- Apoptotic pathways
- The Bcl-2 family
- Apoptosis
- Emerging therapeutic options
- Emerging therapeutic options
- Resisting apoptosis
- Gastric Cancer
- HER1/EGFR as a therapeutic target
- MAPK Signaling
- MEK Inhibitor (GDC-0973)
- Melanoma
- Emerging therapeutic options
- PI3K Inhibitor (GDC-0941)
- Reactivating apoptosis
- PI3K/Akt/mTOR Signaling
- Therapeutic potential of HER pathways
- Traditional Monoclonal Antibodies
- B-cell Surface Proteins
- Glossary
- Direct cell death
- Emerging therapeutic options
- Emerging therapeutic options
- Gastric Cancer
- HER Signaling
- HER1/EGFR as a therapeutic target
- HER2:HER3 dimer
- HER2 as a therapeutic target
- HER3 as a therapeutic target
- Melanoma
- Emerging therapeutic options
- Obinutuzumab (GA101)
- Inhibition of HER2 dimerization
- Therapeutic potential of HER pathways
- Antibody-Drug Conjugates
RAF proteins in the RAS-RAF pathway
The RAF proteins are a family of kinases that serve as an intermediary in transmitting extracellular signals from growth factor receptors in the RAS-RAF pathway, a type of MAPK signaling pathway. This pathway controls cell growth, cell proliferation, and cell differentiation.1,2
LOADING...
The RAS-RAF pathway is a highly conserved pathway necessary for normal cell function. Some biological processes that the pathway controls include cell growth, cell proliferation, and cell differentiation.1
In normal cells, growth factors bind to and activate receptor kinases, which causes a downstream signaling cascade. This eventually leads to the transcription of genes that encode proteins. These proteins regulate essential cellular functions.
RAS-RAF signaling is initiated by receptor tyrosine kinases upon their activation by growth factors in the extracellular space.3
- Activation of the protein RAS causes the membrane recruitment and activation of RAF proteins.3
- In turn, activation of RAF leads to the phosphorylation of MEK, another protein kinase.3
- Next, MEK phosphorylates ERK, a type of MAPK, which can directly and indirectly activate many transcription factors.3
- The activation of these transcription factors then leads to the expression of genes that regulate cell proliferation and survival.3
When mutations in genes within this pathway occur, this could lead to constitutively active proteins. This results in increased cell proliferation and resistance to apoptosis (programmed cell death), both of which can drive cancer.1,3